See also this year's filing and all EDGAR filings for this company.
PDF Report 0001656536_2023_Decibel_Therapeutics_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001656536')"} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 2': 3, '100050 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 11}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001656536, Decibel Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 108,030,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,526,000 |
| 3 | remainder_Assets | 10,817,000 |
| 4 | LiabilitiesCurrent | 22,442,000 |
| 5 | LiabilitiesNoncurrent | 12,373,000 |
| 6 | remainder_Liabilities | 6,765,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 23,627,000 |
| 9 | ResearchAndDevelopmentExpense | 40,330,000 |
| 10 | remainder_Expenses | 240,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,192,000 |
| 13 | remainder_ComprehensiveNetIncome | -91,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 123,373,000 |
| 1 | Liabilities | 41,580,000 |
| 2 | Expenses | 64,197,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 81,793,000 |
| 5 | NetIncome | -63,005,000 |
| 6 | ComprehensiveNetIncome | -63,050,500 |
| 7 | BaseVar | 115,216,500 |
| 8 | EconomicCapitalRatio | 0.941 |
Edgar->Model Mapping
Feature Distribution
Change over Time
